Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years

Importance SARS-CoV-2 vaccines are authorized for use in most age groups. The safety of SARS-CoV-2 vaccines is unknown in children younger than 5 years. Objective To retrospectively evaluate the safety of the BNT162b2 vaccine used off-label in children younger than 5 years compared with the safety o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JAMA network open 2022-10, Vol.5 (10), p.e2237140-e2237140
Hauptverfasser:	Toepfner, Nicole, von Meißner, Wolfgang C. G., Strumann, Christoph, Drinka, Denisa, Stuppe, David, Jorczyk, Maximilian, Moor, Jeanne, Püschel, Johannes, Liss, Melanie, von Poblotzki, Emilie, Berner, Reinhard, Moor, Matthias B., Chao, Cho-Ming
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Cohort analysis Immunization Severe acute respiratory syndrome coronavirus 2 Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!